Cancer

The pharmaceutical sector launched a Framework for Action to tackle non-communicable diseases including cardiovascular disease, cancer, diabetes and chronic respiratory diseases that are posing a threat to public health, and public and private finances worldwide.

Six new collaborative projects have been funded by the UK Technology Strategy Board to advance personalised medicine in cancer and lay foundations for national adoption